Trials / Not Yet Recruiting
Not Yet RecruitingNCT07029867
Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis
Efficacy and Safety of Traditional Chinese Mecicine Yishen Daluo Yin Granule for Relapsing-remitting Multiple Sclerosis: A Randomized Controlled Trial
- Status
- Not Yet Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 152 (estimated)
- Sponsor
- Ying Gao · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to evaluate the efficacy and safety of YSDLY granule in patients with RRMS. This will be a multi-center, randomized, double-blind, placebo-controlled study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Yishen Daluo Yin granuls | The patient takes YSDLY granules or placebo twice a day. |
| DRUG | Placebo | The patient takes placebo (YSDL mimetic granules) twice a day. |
Timeline
- Start date
- 2026-03-15
- Primary completion
- 2026-10-31
- Completion
- 2026-12-31
- First posted
- 2025-06-19
- Last updated
- 2026-02-04
Source: ClinicalTrials.gov record NCT07029867. Inclusion in this directory is not an endorsement.